Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer 

Jessica St. Laurent, MD, was sure something had gone wrong. The results of an experiment she’d run showed that the cancer cells she was studying had abnormally high levels of a specific collection of proteins of interest to her team.  “I remember seeing the gradient and thinking, This can’t be right,” says St. Laurent, who … Read more

Targeted Therapy Offers Hope for Metastatic Cervical Cancer

When Donna McDaniel came to Dana-Farber with what she thought was lung cancer in 2024, she could barely walk and struggled to breathe. She’d been treated elsewhere, but the drugs had seemingly stopped working. Her quality of life was suffering, and she couldn’t keep up with her busy catering job at Blue Cross Blue Shield.  … Read more

Love Comes Full Circle for Patient With Ovarian Cancer

Shelly Sepulveda grew up in Borger, Texas, a Panhandle town with a population of fewer than 10,000 people. A strong sense of connectedness bound the community together, creating long-lasting friendships and a tight-knit feel. When Sepulveda and her wife, Tami, relocated to Medway, Massachusetts, to continue their nursing careers, they found that familiar sense of … Read more

Metastatic Cervical Cancer Survivor Thrives Under Personalized Care 

Like many people, Karen Lagasse has never been a big fan of the dentist. But she’ll always be thankful for a 2013 tooth extraction for paving the way to a life-saving discovery.  Noticing Lagasse’s elevated blood pressure, her dentist asked when she had last visited the doctor. Lagasse admitted it had been a few years, … Read more

TILs: What Are They and How Are They Used in Cancer Treatment?

What is TIL (tumor-infiltrating lymphocyte) therapy? Tumor-infiltrating lymphocyte, or TIL, therapy uses a patient’s own immune system T cells to fight cancer. The therapy involves removing T cells from a piece of the patient’s tumor – where the T cells have congregated after being alerted to the cancer – growing them outside the body, then … Read more

Expanding Options for Patients with Ovarian Cancer 

In 2021, a novel drug called belzutifan was approved by the U.S. Food and Drug Administration (FDA) to treat clear cell renal cell carcinoma, a form of kidney cancer. Since then, Dana-Farber clinical investigator Panos Konstantinopoulos, MD, PhD, has wanted to launch a clinical trial of the drug for clear cell ovarian cancer.  That vision … Read more

Grandmother Continues Life of Adventure on Endometrial Cancer Clinical Trial  

Roberta “Bert” Green is a woman with a full and busy life. When not driving across the country with her husband, Ralph, in their RV, she alternates between paddle boarding, walking, e-biking, and skiing with the changing seasons around her rural Vermont home. Retired after a long career as a school neuropsychologist, she also makes … Read more

With Dana-Farber’s Help, Grandmother Becomes Great Grandmother 

Six years ago, Ina Kornetsky was looking forward to a new chapter in her life. The lifelong teacher had most recently worked with older adults before retiring, and she had a deep understanding of the kind of life she wanted as she approached 90. She was preparing to move from Stoughton, Mass. into a continuing … Read more

Cervical Cancer Disparities: What to Know and Tips for Prevention 

Cervical cancer is caused by a virus called HPV (human papilloma virus) that is spread through sexual contact. For many people, the virus is cleared by the immune system. But if it isn’t, it can develop into cancer.   The virus can be detected through HPV screening that inspects a sample of cervical tissue for the … Read more

Boston Marathon Run is Mother-Daughter Moment for Breast and Uterine Cancer Survivor 

Runners call it Heartbreak Hill, but for Michelle O’Brien the long, rising stretch of pavement that crosses the 20-mile point of the Boston Marathon® route represents the top of the mountain.   Just over three years after being diagnosed in back-to-back months with two unrelated cancers — invasive breast cancer in December 2020, and then stage … Read more

How Dana-Farber Investigators Seize Opportunities to Advance Medicine

Investigators who run investigator-initiated trials (IITs) have two essential qualities. One is curiosity, which keeps them alert, aware of discoveries, and able to make connections that lead to new treatment ideas.   The second is determination.   “The burden of responsibility for what is typically a many-year-long study falls on that one investigator,” says Ursula Matulonis, MD, … Read more

Lessons From a Lawyer Living with Ovarian Cancer 

Jennifer Thorn has worked hard her whole life running a family law practice and raising her family, but in April 2021, just as she began to enjoy her success, she faced a new challenge.  After experiencing pain while lying on her side, Thorn, 48, of Wilbraham, Massachusetts, visited her primary care physician who ordered bloodwork … Read more

What’s the Connection Between BRCA and Ashkenazi Jewish Ancestry? 

People who inherit mutations in the BRCA1 or BRCA2 gene are at heightened risk for a variety of cancers, including breast, ovarian, prostate, and pancreatic. It’s estimated that one in 300-400 people in the general population carry a mutation in either of these genes. Among people of Ashkenazi (Eastern European) Jewish descent, the prevalence is … Read more

Living with Recurrent Ovarian Cancer, Celebrity Chef Writes a New Recipe 

As a cast member on the television series “America’s Test Kitchen,” and host of its companion podcast “The Walk-In,” Elle Simone Scott delights in sharing her expertise and recipes. The Boston-based celebrity chef and food stylist is also a role model, as founder and president of SheChef, Inc., a professional networking organization for fellow women … Read more